Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1991-1-22
|
pubmed:abstractText |
Alveolar macrophages and their products are thought to be important mediators of the inflammatory lesions and consequent interstitial fibrosis caused by inhalation of inorganic particles. Identification of a homolog of platelet-derived growth factor (PDGF) produced by rat alveolar macrophages that were stimulated with carbonyl iron particles and asbestos fibers motivated our studies on the biologic activity of this potent cytokine. Macrophage-derived PDGF (MD-PDGF) competes for specific membrane receptors on rat lung fibroblasts, initiating DNA synthesis and cell replication. The present report demonstrates that purified human PDGF and the MD-PDGF are chemotactic for early passage rat lung fibroblasts, but not for lung macrophages. Rat lung fibroblasts exhibit a typical bell-shaped, dose-related curve and respond optimally between 2 and 4 ng/ml PDGF. We found that alveolar macrophage-conditioned medium (AMCM), fractionated by gel filtration in 1 M acetic acid, induced a clear chemotactic response in the same fractions (20 to 22 ml) where PDGF was identified by enzyme immunoassay. In contrast, AMCM fractionated by gel filtration in phosphate-buffered saline did not induce any chemotactic activity unless the fractions were treated further with 1 M acetic acid. In this case, chemotactic activity was observed in those fractions with molecular weights of 150 and greater than 200 kD. All chemotactic activity observed with fractionated AMCM was blocked greater than 90% by an anti-PDGF antibody. These observations demonstrate that MD-PDGF is chemotactic for rat lung fibroblasts if it first is released from its binding protein, alpha-macroglobulin (alpha-M), which is secreted into the medium along with PDGF.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1044-1549
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
595-602
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1701306-Animals,
pubmed-meshheading:1701306-Cells, Cultured,
pubmed-meshheading:1701306-Chemotaxis,
pubmed-meshheading:1701306-Fibroblasts,
pubmed-meshheading:1701306-Humans,
pubmed-meshheading:1701306-Immunoenzyme Techniques,
pubmed-meshheading:1701306-Lung,
pubmed-meshheading:1701306-Macrophages,
pubmed-meshheading:1701306-Male,
pubmed-meshheading:1701306-Molecular Weight,
pubmed-meshheading:1701306-Platelet-Derived Growth Factor,
pubmed-meshheading:1701306-Pulmonary Alveoli,
pubmed-meshheading:1701306-Rats,
pubmed-meshheading:1701306-alpha-Macroglobulins
|
pubmed:year |
1990
|
pubmed:articleTitle |
Rat alveolar macrophage-derived platelet-derived growth factor is chemotactic for rat lung fibroblasts.
|
pubmed:affiliation |
Laboratory of Pulmonary Pathobiology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709.
|
pubmed:publicationType |
Journal Article
|